← FDA Drug Approvals (Drugs@FDA)
SIPONIMOD
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: RICONPHARMA LLC · Approved 2025-04-22
Drug application
- FDA Application #
ANDA218444- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- SIPONIMOD
- Generic name
- Siponimod
- Active ingredients
- SIPONIMOD
- Dosage form
- TABLET
- Route
- ORAL
- Marketing status
- Discontinued
- Sponsor
- RICONPHARMA LLC
- First approval
- 2025-04-22
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown